Need a specific person's email?
Browse PhaseBio Pharmaceuticals, Inc.'s employee directory (about 11 employees) and reveal verified emails free.
PhaseBio Pharmaceuticals, Inc.'s most common email format is First.Last@phasebio.com (ex. John.Doe@phasebio.com), used for 95% of phasebio.com addresses. PhaseBio Pharmaceuticals, Inc. uses 2 email patterns.
| Format | Example | Share of phasebio.com |
|---|---|---|
| First.Last@phasebio.comMost common | John.Doe@phasebio.com | |
| FLast@phasebio.com | JDoe@phasebio.com |
Browse PhaseBio Pharmaceuticals, Inc.'s employee directory (about 11 employees) and reveal verified emails free.
Biotechnology ResearchPennsylvania, United States11-50 Employees
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing therapies for cardiovascular and cardiopulmonary diseases. Its pipeline includes bentracimab (PB2452), a reversal agent for ticagrelor; pemziviptadil (PB1046), a once-weekly agent that activates the vasoactive intestinal peptide receptor and is being developed for pulmonary arterial hypertension; and PB6440, an oral treatment for resistant hypertension. The company relies on an elastin-like polypeptide platform to improve pharmacokinetic profiles and potentially reduce dosing frequency, supporting both internal programs and collaborative development efforts. Based in Malvern, Pennsylvania, PhaseBio operates in the biotechnology research sector with a relatively small to mid-sized team. The company is focused on advancing its clinical-stage candidates toward possible clinical use and exploring partnership opportunities.
Most common format
First.Last@phasebio.com
Example: John.Doe@phasebio.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.